We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Council on Pharmacy and Chemistry

JAMA. 1941;117(14):1182-1183. doi:10.1001/jama.1941.02820400040011.
Text Size: A A A
Published online


McLester, J. S.:  Studies on Uric Acid of Blood and Urine, with Special Reference to the Influence of Atophan , Arch. Int. Med. 12: 739 ( (Dec.) ) 1913.
Link to Article[[XSLOpenURL/10.1001/archinte.1913.00070060131009]]
Barbour, H. G., and Lozinsky, E.:  Nontoxicity and Antipyretic Efficiency of Tolysin , J. Lab. & Clin. Med. 8:217 ( (Jan.) ) 1923.
Furth, O., and Kuh, E.:  Biochemical Studies on Absorption of Ethylester of Paramethylphenylcinchoninic Acid (Tolysin) and Its Fate in Metabolism: Fate of Tolysin in Metabolism and Its Toxicity , J. Pharmacol. & Exper. Therap. 38:71 ( (Jan.) ) 1930.
Barbour, H. G., and Gilman, Alfred:  Cinchophen and Paramethylphenyl Cinchoninic Acid Ethyl Ester (Tolysin): A Comparison of the Effects of Administration in Rats , J. Pharmacol. & Exper. Therap. 55:400 ( (Dec.) ) 1935.
von Oettingen, W. F.: The Therapeutic Agents of the Quinoline Group , New York, Chemical Catalog Company, Inc., 1933.
Palmer, W. L., and Woodall, P. S.:  Cinchophen—Is There a Safe Method of Administration? J. A. M. A. 107:760 ( (Sept. 5) ) 1936.
White, E. P. C.:  Study on Series of Arthritic Patients Under Continuous Mono-Iodo-Cinchophen Treatment with Special Reference to Action of Cinchophen Molecule on Liver Tract , J. Lab. & Clin. Med. 17: 17 ( (Oct.) ) 1931.
Snyder, R. G., and others:  The Use of Cinchophen in the Treatment of Chronic Arthritis , J. Lab. & Clin. Med. 21: 541 ( (Feb.) ) 1936.
Weir, J. F., and Comfort, M. W.:  Toxic Cirrhosis Caused by Cinchophen , Arch. Int. Med. 52:685 ( (Nov.) ) 1933.
Quick, A. J.:  Probable Allergic Nature of Cinchophen Poisoning with Special Reference to Arthus Phenomenon and with Precautions to Be Followed in Cinchophen Administration , Am. J. M. Sc. 187:115 ( (Jan.) ) 1934.
Fink, A. I.:  Cinchophen Poisoning in Allergic Individuals: Report of Two Cases , J. Allergy 1:280 ( (March) ) 1930.
Short, C. L., and Bauer, Walter:  Cinchophen Hypersensitiveness: Report of Four Cases and Review , Ann. Int. Med. 6: 1449 ( (May) ) 1933.
Hench, P. S., in discussion on Palmer, W. L., and Woodall, P. S.:  Cinchophen—Is There a Safe Method of Administration?  abstr. J. A. M. A. 106:327 ( (Jan. 25) ) 1936.
Köhne, Gisbert:  Leberschädigung nach Atophanpräparaten , Klin. Wchnschr. 17:887 ( (June 18) ) 1938.
Brugsch, T., and Horsters, Hans:  Cholerese und Choleretica, ein Beitrag zur Physiologie der Galle , Ztschr. f. d. ges. Med. 38:367 ( (Aug. 13) ) 1923.
Opie, Eugene L., and Alford, Leland B.:  The Influence of Diet on Healthy Necrosis and Toxicity of Chloroform , J. A. M. A. 62:895 ( (March 21) ) 1914.
Boros, Edwin:  Hay Fever and Asthma During and After Jaundice: Ascites Due to Cinchophen Poisoning , J. A. M. A. 109: 113 ( (July 10) ) 1937.
Evans, G., and Spence, A. W.:  Phenylcinchoninic Acid (Cinchophen) in Treatment of Gout , Lancet 1:704 ( (April 6) ) 1929.
Eimer, Karl:  Atophanvergiftung und ihre Behandlung , Deutsche med. Wchnschr. 51:1663 ( (Sept. 25) ) 1931.
Davis, J. S., Jr.:  Relation of Neocinchophen to Question of Cinchophen Toxicity , Am. J. M. Sc. 184:555 ( (Oct.) ) 1932.
Eaton, Ernest Risley:  A Systemic Treatment for Chronic Arthritis , Clin. Med. & Surg. 42:224 ( (May) ) 1935.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.